Fast Colony Forming Unit Counting in 96-Well Plate Format Applied to the Drosophila Microbiome
January 13th, 2023
This method quantifies microbial abundance using a 96-well plate format to plate colony forming units (CFUs) and is applied to the Drosophila microbiome in whole fly homogenate samples. CFUs are counted with an automated image analysis software provided here.
Overview
This study introduces a rapid and automated method for quantifying microbial abundance using a 96-well plate format, significantly improving the speed of colony forming unit (CFU) counting. The technique is applied to examine the gut microbiome of Drosophila, providing important insights into the methodology used for analyzing small animal models.
Key Study Components
Research Area
- Microbial abundance quantification
- Gnotobiotic studies in small animal models
Background
- Traditional CFU counting methods are time-consuming and require numerous agar plates.
- This method allows for a more efficient workflow, particularly relevant in microbiology.
Methods Used
- Automated image analysis software for counting CFUs
- Whole fly homogenate samples from Drosophila
- DIY-fabricated instrumentation for image acquisition
Main Results
- The protocol offers a hundred-fold time advantage over traditional methods for plating and counting.
- Demonstrated efficient handling of gnotobiotic flies and automated counting thresholds.
Conclusions
- The study validates an effective protocol for microbiome analysis in small organisms.
- This method enhances potential applications in various microbiological experiments.
Frequently Asked Questions
Executive Industry Relevance
High-throughput, quantitative colony forming unit (CFU) counting in 96-well plate format accelerates microbiome research in small animal models and in vitro systems. This workflow enables rapid, reproducible quantification of microbial abundance, supporting robust target validation and mechanistic de-risking in discovery-stage biopharma pipelines. Automated image analysis and scalable sample handling reduce bottlenecks in screening and translational microbiology workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise quantification of microbial colonization for hypothesis-driven studies.
- Supports functional validation of host-microbe interactions in genetically tractable models.
- Facilitates mechanistic de-risking by distinguishing biological from technical variation.
- Improves predictive confidence in microbiome-related target selection.
Screening & Assay Development
- Prepares validated, high-throughput biological systems for compound or genetic screening.
- Standardizes CFU quantification with automated, reproducible image analysis.
- Delivers quantitative outputs suitable for comparative and dose-response studies.
- Enables scalable screening of microbial or host genetic perturbations.
Translational & Preclinical Research
- Aligns microbial abundance measurements with disease-relevant phenotypes in model organisms.
- Supports continuity from discovery through preclinical validation of microbiome interventions.
- Enables risk-adjusted advancement of microbiome-modulating candidates.
- Provides quantitative endpoints for translational biomarker development.
Pipeline & Workflow Integration
This method integrates from early discovery through screening and preclinical research, supporting workflows from hypothesis testing to lead identification in microbiome-focused programs.
- Discovery Biology: Quantitative CFU counting enables robust null hypothesis testing and pathway clarification in host-microbe studies.
- Screening: Automated, reproducible outputs facilitate assay readiness and high-throughput screening scalability.
- Analytics: Image-based quantification and CSV data outputs support statistical comparison across experimental conditions.
- Translational Research: Quantitative microbial abundance aligns with preclinical endpoints for candidate evaluation.
- Enterprise Reuse: The workflow is adaptable to other small animal models and in vitro systems for broad R&D utility.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in microbiome studies.
- Operational Value: Standardizes and accelerates CFU quantification with scalable, automated processes.
- Strategic Value: Enables better go/no-go decisions and capital efficiency by reducing manual bottlenecks.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of microbiome-targeted assets.
Implementation Considerations
- Requires manual dexterity for sample handling and plate spotting.
- Needs access to imaging instrumentation and compatible analysis software (e.g., ImageJ plugins).
- Demands cross-team standardization of threshold settings and validation against manual counts.
- Adaptable to various microbial species and fluorescent markers with parameter adjustments.
- Accuracy may decrease at high colony densities due to spot overlap; calibration is essential.
Biopharma FAQs
Chapters in this video
0:04
Introduction
1:28
Homogenizing Flies Individually in a 96-Well PCR Plate
4:13
Serial Dilution of Fly Homogenate and Spotting onto CFU Plates
6:03
Quantification of CFUs
6:44
Automated Colony Counting Using the Count-On-It Suite
9:57
Results: Enumeration of CFUs Using Automated Colony Counting
12:10
Conclusion
